Large-scale testing (Phase 3)Study completedNCT03766295What this trial is testingMasitinib Plus Gemcitabine in Pancreatic CancerWho this might be right forLocally Advanced or Metastatic Pancreatic Cancer AB Science 377
Testing effectiveness (Phase 2)WithdrawnNCT05251038What this trial is testingStudy of Sotorasib Combined With Chemotherapy for Second Line Treatment of Pancreas CancerWho this might be right forPancreatic CancerUnresectable Pancreatic CancerMetastatic Pancreatic Cancer+1 more Devalingam Mahalingam
Early research (Phase 1)Study completedNCT01487785What this trial is testingDose-escalation, and Safety Study of LDE225 and Gemcitabine in Locally Advanced or Metastatic Pancreatic Cancer PatientsWho this might be right forPancreatic Cancer Novartis Pharmaceuticals 18
Testing effectiveness (Phase 2)Ended earlyNCT03723915What this trial is testingPembrolizumab and Pelareorep in Treating Patients With Advanced Pancreatic CancerWho this might be right forPancreatic AdenocarcinomaStage III Pancreatic Cancer AJCC v8Stage IV Pancreatic Cancer AJCC v8 Northwestern University 17
Testing effectiveness (Phase 2)Active Not RecruitingNCT05481476What this trial is testingSurufatinib Combined With Sintilimab and AG in First-line Therapy of Patients With Locally Advanced or Metastatic Pancreatic CancerWho this might be right forPancreatic Neoplasms Sun Yat-sen University 32
Not applicableApproved For MarketingNCT00786058What this trial is testingA Phase III Second Line Trial in Advanced Pancreatic Cancer CONKO 003Who this might be right forPancreatic Cancer CONKO-Studiengruppe
Not applicableNot Yet RecruitingNCT07839676What this trial is testingA Prospective Study of Concurrent Hyperthermia, Chemotherapy and Radiotherapy in Borderline and Locally Advanced Pancreatic Cancer (PANHEAT)Who this might be right forBorderline and Locally Advanced Pancreatic Cancer Fernando Pessoa Canarias University 60
Testing effectiveness (Phase 2)Ended earlyNCT06630325What this trial is testingA Precision Medicine Approach (SMMART-ACT) for the Treatment of Patients With Advanced Sarcoma, Prostate, Breast, Ovarian or Pancreatic CancerWho this might be right forAdvanced Breast CarcinomaAdvanced Malignant Solid NeoplasmAdvanced Ovarian Carcinoma+11 more OHSU Knight Cancer Institute 6
Not applicableStudy completedNCT06118125What this trial is testingDelay to Diagnosis in Digestive Cancerology by the General Practitioner Related to Covid-19 Pandemic ConfinementWho this might be right forNeoplasms, ColorectalGeneral PractitionerPandemic, COVID-19+4 more University of Bordeaux 376
Testing effectiveness (Phase 2)Study completedNCT00025168What this trial is testingCombination Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Unresectable Pancreatic CancerWho this might be right forPancreatic Cancer Wake Forest University Health Sciences 20
Testing effectiveness (Phase 2)UnknownNCT04571489What this trial is testingA Phase II Study of Gimatecan (ST1481) in Locally Advanced or Metastatic Pancreatic CancerWho this might be right forPancreatic Cancer Lee's Pharmaceutical Limited 60
Not applicableEnded earlyNCT02900248What this trial is testingCureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician ChoiceWho this might be right forNeoplasmsLung NeoplasmsColon Neoplasms+22 more CureOne 23
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07446270What this trial is testingEfficacy of Tunlametinib in Combination With Anti-EGFR Monoclonal Antibody in Patients With RAS-Mutated Advanced Gastrointestinal MalignanciesWho this might be right forTreatment for Advanced Colorectal CancerTreatment for Advanced Pancreatic Cancer Chinese PLA General Hospital 90
Large-scale testing (Phase 3)Not Yet RecruitingNCT06492941What this trial is testingDocetaxel for Injection (Albumin Bound) in Patients With Advanced Pancreatic CancerWho this might be right forAdvanced Pancreatic Cancer CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 142
Early research (Phase 1)Ended earlyNCT01233505What this trial is testingVeliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid TumorsWho this might be right forAdenocarcinoma of the PancreasAdenocarcinoma of the StomachBRCA1 Mutation Carrier+23 more National Cancer Institute (NCI) 16
Early research (Phase 1)Study completedNCT00475956What this trial is testingSafety and Tolerability Study of AZD2171 in Combination With AZD0530 in Patients With Advanced Solid TumoursWho this might be right forNeoplasms AstraZeneca 40
Large-scale testing (Phase 3)Study completedNCT05840341What this trial is testingClinical Efficacy of QYHJ and Standard Chemotherapy in the Treatment of Advanced Pancreatic CancerWho this might be right forPancreatic Neoplasms Fudan University 305
Early research (Phase 1)Active Not RecruitingNCT05156866What this trial is testingFirst in Human Study of TORL-2-307-ADC in Participants With Advanced CancerWho this might be right forAdvanced Solid TumorGastric CancerPancreas Cancer+1 more TORL Biotherapeutics, LLC 163
Not applicableActive Not RecruitingNCT02921022What this trial is testingStudy Of Gemcitabine, Nab-paclitaxel, PEGPH20 and Rivaroxaban for Advanced Pancreatic AdenocarcinomaWho this might be right forPancreatic CancerAdvanced Pancreatic Ductal Adenocarcinoma Memorial Sloan Kettering Cancer Center 110
Testing effectiveness (Phase 2)UnknownNCT02839954What this trial is testingCAR-pNK Cell Immunotherapy in MUC1 Positive Relapsed or Refractory Solid TumorWho this might be right forHepatocellular CarcinomaNon-small Cell Lung CancerPancreatic Carcinoma+4 more PersonGen BioTherapeutics (Suzhou) Co., Ltd. 10